Authors:
Monali Tayade, Shweta Bisht
Download free PDF
Diagnostic Ultrasound Market Size & Share 2026-2035
Report ID: GMI1915
|
Published Date: October 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Diagnostic Ultrasound Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Diagnostic Ultrasound Market Size
The diagnostic ultrasound market was valued at USD 8.50 billion in 2025, is projected to reach USD 8.90 billion in 2026, and is expected to grow at a 4.7% CAGR (2026–2035) to reach USD 13.46 billion by 2035.
Diagnostic Ultrasound Market Key Takeaways
Market Leader: GE Healthcare led with over 27% market share in 2025.
Leading Players: Top 5 players in this market include GE Healthcare, Philips, Siemens Healthineers, Mindray, Samsung Medison, which collectively held a market share of 82% in 2025.
Diagnostic ultrasound remains a first-line imaging modality because it provides real-time anatomical and functional assessment without ionizing radiation, while serving a broad clinical base spanning abdominal, obstetric, cardiac, vascular, and musculoskeletal care. Demand is evolving from centralized diagnostic departments toward a more distributed care model in which workflow automation, portability, and application-specific transducer capability determine the addressable setting as much as image quality does.
GMI Analyst View
Our discussions with industry experts indicate that the diagnostic ultrasound market registered USD 7.35 billion in 2022, establishing the growth trajectory that has carried market revenues consistently forward through the historic period and into the 2026–2035 forecast window.
Diagnostic Ultrasound Market Trends, Growth Drivers & GMI Forecast Outlook
The market outlook reflects an expanding recurring procedure base rather than a one-time equipment cycle. Aging, chronic disease surveillance, and decentralized care are broadening demand, while the pace at which providers solve workforce, reimbursement, and maintenance constraints will determine how fully clinical need converts into equipment and software revenue.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Population aging raises ultrasound demand through both case complexity and repeat utilization. Older patients are more likely to enter longitudinal care pathways requiring cardiac, renal, vascular, and abdominal monitoring, which supports recurring scan activity rather than isolated examinations. This favors systems that can move across specialties and deliver consistent image acquisition in high-throughput settings.
The chronic-disease burden reinforces this pattern because ultrasound is embedded in monitoring pathways for cardiovascular, metabolic, hepatic, and renal conditions. Cardiovascular diseases caused at least 19 million deaths in 2021 [2]World Health Organization. "Noncommunicable Diseases." who.int, underscoring the scale of the patient population that requires diagnosis and continued surveillance. Doppler capability, echocardiographic functionality, and advanced visualization therefore benefit from an installed-base need tied to clinical follow-up, not solely to new diagnostic referrals.
AI changes the commercial threshold for adoption by making image acquisition and documentation more repeatable for users outside specialist sonography teams. As guidance, automated measurements, and structured workflows become more available across system tiers, providers can consider ultrasound in emergency, primary-care, maternity, and rural environments that previously lacked sufficient operator capacity. The resulting opportunity includes equipment sales, software-enabled upgrades, and a broader base of clinicians using imaging at the point of care.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Cost restraints in emerging markets extend beyond the device purchase price. Training, probe replacement, service coverage, connectivity, and financing determine whether equipment can be deployed productively over its useful life. A lower-priced portable system may improve initial accessibility, but it does not eliminate the operational requirements needed to sustain diagnostic quality and revenue-generating utilization.
In mature markets, workforce scarcity more directly constrains throughput and replacement decisions. Providers may prioritize systems that reduce scanning variability, automate measurements, or shorten reporting workflows before committing to wholesale fleet replacement. That dynamic increases the strategic importance of software integration and service support, especially for outpatient imaging operators and community hospitals facing staffing pressure.
Reimbursement fragmentation creates a separate commercialization challenge. Where procedure economics are uncertain, providers may defer upgrades, prolong equipment use, or limit services to applications with clearer funding. Manufacturers seeking durable expansion in lower-income settings must therefore pair product strategy with local training, service, and financing capabilities rather than treating demand growth as a hardware-distribution opportunity alone.
GMI Analyst View
We view workforce capacity and care-delivery economics as the central variables separating clinical need from realized market demand. Providers that can pair compact imaging with dependable training, workflow support, and service coverage should capture a larger share of decentralized care, while suppliers reliant on hardware specifications alone may face slower conversion outside established imaging departments.
Diagnostic Ultrasound Market Segment Analysis
By Technology
2D Ultrasound
2D ultrasound accounted for 35.0% of diagnostic ultrasound market revenue in 2025 and is projected to account for 29.0% in 2035. Its broad clinical utility, familiar operating workflows, and lower entry cost preserve substantial procurement demand across general imaging, obstetric care, and primary-care settings, even as advanced modalities capture a greater proportion of revenue.
3D & 4D ultrasound generated USD 2.38 billion in 2025 and is projected to expand at a 6.4% CAGR (2026–2035). Volumetric visualization supports differentiation in maternal-fetal medicine, cardiac morphology assessment, and intervention planning, where clinical confidence and visualization detail can justify premium system configurations.
Doppler Ultrasound
Doppler ultrasound represented 37.0% of global revenue in 2025 and is projected to generate USD 5.12 billion by 2035. Its role in blood-flow assessment makes it integral to cardiovascular, vascular, and obstetric pathways, giving the segment exposure to the recurring monitoring needs associated with aging populations and chronic disease management.
By Portability
Trolley/Cart-Based
Trolley/cart-based systems held 72.0% of diagnostic ultrasound market revenue in 2025 and are projected to hold 61.5% in 2035. These systems remain essential in high-acuity departments requiring broad transducer portfolios, advanced imaging capability, and integration with established clinical workflows, although their relative weight declines as decentralized use cases expand.
Compact/Handheld (POCUS)
Compact/handheld point-of-care ultrasound systems are projected to generate USD 5.18 billion by 2035 and grow at an 8.1% CAGR (2026–2035). Miniaturization, AI-guided acquisition, and increasingly flexible software models are making these systems viable across emergency medicine, community clinics, perioperative care, and rural health delivery.
By Application
General Imaging
General imaging generated USD 3.23 billion in 2025 and is projected to account for 35.0% of diagnostic ultrasound market revenue in 2035. The category benefits from a wide procedural base that includes abdominal, thyroid, soft-tissue, and guided-intervention examinations, sustaining demand across both premium and value-oriented equipment tiers.
Cardiology
Cardiology is projected to generate USD 3.90 billion by 2035 and represented 26.0% of market revenue in 2025. Echocardiography, vascular evaluation, and functional cardiac assessment make the category a major beneficiary of the technology shift toward Doppler, advanced visualization, and AI-assisted quantification.
OB/GYN
OB/GYN accounted for 21.0% of diagnostic ultrasound market revenue in 2025 and is projected to generate USD 2.82 billion by 2035. Antenatal screening, fetal growth monitoring, and maternal-fetal assessment provide a predictable examination base, while automated standard-plane detection can improve consistency in settings with limited specialist availability.
Other Applications (MSK, Vascular, Urology)
Other applications are projected to generate USD 2.01 billion by 2035 and grow at a 4.7% CAGR (2026–2035). Musculoskeletal, vascular, and urological use cases are expanding with high-frequency transducers and point-of-care workflows that allow specialists to evaluate anatomy dynamically during consultation and procedures.
By End Use
Hospitals
Hospitals held 62.0% of diagnostic ultrasound market revenue in 2025 and are projected to account for 56.0% in 2035. They remain the principal setting for high-acuity imaging and advanced cardiology, but their relative share is reduced by the migration of appropriate examinations to outpatient, ambulatory, and point-of-care environments.
Maternity Centers
Maternity centers generated USD 1.02 billion in 2025 and are projected to grow at a 5.5% CAGR (2026–2035). Their focused procedure mix creates recurring demand for fetal imaging and antenatal monitoring, particularly where maternal-health programs are expanding access to structured screening.
Other (Clinics, Diagnostic Labs, Ambulatory Surgical Centers)
Other end users, including clinics, diagnostic laboratories, and ambulatory surgical centers, are projected to generate USD 4.17 billion by 2035 and grow at a 6.6% CAGR (2026–2035). This channel captures the commercial effect of decentralized imaging, as lower-footprint systems and workflow automation make ultrasound more practical outside centralized hospital radiology departments.
GMI Analyst View
We see portability as the connective commercial theme across technology, application, and end-use segmentation. The most attractive demand pools are increasingly those where clinical capability can be delivered closer to the patient, provided manufacturers can preserve image confidence, simplify workflow, and support nontraditional users without compromising care standards.
Diagnostic Ultrasound Market Regional Analysis
North America Diagnostic Ultrasound Market Analysis
The Diagnostic Ultrasound Market in North America is projected to account for 33.8% of global revenue by 2035 and generated USD 2.89 billion in 2025. Mature reimbursement structures, dense installed equipment bases, and rapid adoption of AI-enabled workflow features sustain replacement demand, while outpatient and point-of-care adoption broadens the region's purchasing base.
United States
The United States is projected to generate USD 4.04 billion by 2035, compared with USD 2.55 billion in 2025. Academic medical centers, private outpatient networks, and strong demand for premium cardiac and women's-health imaging support a market in which software integration and clinical workflow interoperability increasingly influence purchasing decisions.
Canada
Canada accounted for 4.0% of global revenue in 2025 and is projected to grow at a 4.0% CAGR (2026–2035). Provincial capital-planning cycles can slow replacement timing, but use of portable ultrasound in emergency, internal medicine, and teaching environments is expanding demand beyond traditional radiology procurement.
Europe Diagnostic Ultrasound Market Analysis
Europe accounted for 22.0% of global revenue in 2025 and is projected to generate USD 2.94 billion by 2035. Aging populations and high clinical standards provide a durable demand base, while constrained public capital budgets favor selective upgrades that deliver measurable workflow, diagnostic, or specialty-care benefits.
Germany
Germany is projected to generate USD 695 million by 2035, compared with USD 440 million in 2025. Its dense network of hospitals, specialist practices, and cardiovascular centers supports demand for premium systems, while clinician-performed ultrasound creates incremental opportunities outside central imaging departments.
United Kingdom
The United Kingdom accounted for 3.6% of global revenue in 2025 and is projected to generate USD 486 million by 2035. Public procurement frameworks and workforce pressure encourage interest in systems that improve scan consistency and productivity, while private imaging providers broaden the channel for portable and specialty platforms.
France
France generated USD 290 million in 2025 and is projected to grow at a 4.6% CAGR (2026–2035). Its public-private care model and established radiology and cardiology networks support recurring imaging demand, with advanced cardiac and maternal-fetal applications driving measured upgrades in system capability.
Italy
Italy is projected to generate USD 314 million by 2035 and accounted for 2.4% of global revenue in 2025. The country's established use of ultrasound by internists and specialists broadens the buyer base for portable and mid-tier platforms while tertiary facilities remain an important outlet for advanced imaging systems.
Spain
Spain is projected to account for 2.0% of global revenue in 2035 and generated USD 175 million in 2025. Digital-health investment and primary-care imaging initiatives support wider access, although public-sector fiscal discipline may continue to shape the timing of capital-equipment replacement.
Netherlands
The Netherlands generated USD 110 million in 2025 and is projected to grow at a 4.6% CAGR (2026–2035). A high-density primary-care network and strong specialist referral system create a disciplined utilization environment, while point-of-care adoption adds demand in teaching hospitals and outpatient specialty practices.
Asia Pacific Diagnostic Ultrasound Market Analysis
The Diagnostic Ultrasound Market in Asia Pacific is projected to generate USD 4.73 billion by 2035 and accounted for 35.0% of global revenue in 2025. The region combines high-income replacement markets with large new-installation opportunities, requiring suppliers to balance premium clinical capability, affordability, localized service, and training support.
China
China is projected to generate USD 2.09 billion by 2035 and accounted for 16.0% of global revenue in 2025. Healthcare infrastructure expansion and domestic manufacturing scale support demand across price tiers, while competitive local suppliers intensify pressure in mid-tier systems and accelerate adoption of AI-assisted functionality.
Japan
Japan generated USD 680 million in 2025 and is projected to generate USD 1.00 billion by 2035. Its aging population, high imaging utilization, and specialist-led clinical practice sustain demand for high-resolution systems in hepatology, cardiology, vascular care, and cancer surveillance.
India
India generated USD 425 million in 2025 and is projected to grow at a 6.5% CAGR (2026–2035). Private hospital expansion, maternal-health programs, chronic-disease growth, and rural-care investment create a broad demand base, with compact systems gaining relevance where cost and operator availability remain decisive.
South Korea
South Korea is projected to generate USD 403 million by 2035 and accounted for 3.0% of global revenue in 2025. Domestic medical-device capability supports a competitive mid-to-premium market, while advanced hospital networks and growing handheld adoption sustain demand across tertiary and community settings.
Australia
Australia generated USD 170 million in 2025 and is projected to account for 2.0% of global revenue in 2035. Private imaging networks and established reimbursement support a stable procedure base, while remote-care needs and telehealth-enabled interpretation expand the case for portable ultrasound deployment outside metropolitan centers.
Latin America Diagnostic Ultrasound Market Analysis
Latin America generated USD 425 million in 2025 and is projected to generate USD 668 million by 2035. Private-provider expansion and demand for compact systems support growth, but fragmented coverage, financing limitations, and macroeconomic variability continue to influence procurement timing and service-network economics.
Brazil
Brazil accounted for 3.0% of global revenue in 2025 and is projected to generate USD 401 million by 2035. Large private hospital networks and public-sector community-health procurement support demand across system tiers, although import exposure leaves purchasing patterns sensitive to currency and trade conditions.
Mexico
Mexico generated USD 85 million in 2025 and is projected to grow at a 4.6% CAGR (2026–2035). Public tender cycles remain important to institutional demand, while private diagnostics and maternal-health programs provide additional channels for portable and mid-tier ultrasound systems.
Argentina
Argentina is projected to generate USD 66 million by 2035 and accounted for 0.5% of global revenue in 2025. Underlying clinical demand is supported by specialist practice and hospital coverage, but macroeconomic instability can disrupt capital-equipment procurement and prolong replacement cycles.
Middle East & Africa Diagnostic Ultrasound Market Analysis
Middle East & Africa accounted for 4.0% of global revenue in 2025 and is projected to grow at a 5.4% CAGR (2026–2035). Healthcare investment, urban population growth, and expanding diagnostic access support demand, although workforce development, reimbursement consistency, and maintenance infrastructure remain essential to converting opportunity into sustained equipment utilization.
Saudi Arabia
Saudi Arabia generated USD 136 million in 2025 and is projected to generate USD 229 million by 2035. Healthcare transformation investment and specialist-center development support demand across maternal health, cardiology, and radiology modernization, creating a meaningful market for both premium and scalable imaging platforms.
UAE
The UAE accounted for 1.0% of global revenue in 2025 and is projected to grow at a 5.7% CAGR (2026–2035). Premium care infrastructure and a growing private clinic base make the country an important regional adoption setting for advanced, AI-enabled imaging systems and integrated clinical workflows.
South Africa
South Africa generated USD 68 million in 2025 and is projected to generate USD 108 million by 2035. Its sophisticated private healthcare sector supports mid-to-premium demand, while the future pace of public-sector expansion depends on the implementation path of national health coverage and related procurement frameworks.
GMI Analyst View
We believe regional performance will be determined less by headline demographic potential than by each market's ability to operationalize ultrasound at scale. Mature regions reward workflow-led replacement strategies, whereas emerging markets favor suppliers that can combine appropriate system design with local training, financing, and dependable post-installation support.
Diagnostic Ultrasound Market Share & Competitive Landscape
The diagnostic ultrasound market share is concentrated among established global OEMs, with the top five manufacturers accounting for approximately 82% of revenue in 2025. Competitive advantage rests on clinical image quality, transducer portfolios, AI-enabled workflow capability, installed-base service coverage, and the ability to serve both premium hospital systems and increasingly decentralized care environments.
GE Healthcare
GE Healthcare held approximately 27% of market revenue in 2025. Its positioning spans premium cardiology and women's-health systems, general imaging platforms, and handheld devices, while its investment in clinical AI supports a strategy centered on workflow automation and differentiated imaging performance.
Philips
Philips held 18% of market revenue in 2025. The company competes most strongly where echocardiography, integrated decision support, connectivity, and health-system relationships shape equipment selection, giving its cloud-enabled and enterprise-oriented approach relevance beyond the initial hardware transaction.
Siemens Healthineers
Siemens Healthineers held 17% of market revenue in 2025. Its premium positioning in radiology, cardiology, and high-acuity care is reinforced by enterprise-imaging integration and AI-assisted analysis, particularly in hospital environments where diagnostic precision and interoperability are central procurement criteria.
Mindray and Samsung Medison
Mindray's competitive strength is rooted in broad product coverage, cost-competitive offerings, expanding distribution, and growing AI capability, particularly across Asia Pacific and other emerging markets. Samsung Medison remains differentiated by its focus on women's health, fetal imaging, and AI-enabled ultrasound applications, where specialized clinical workflows and imaging confidence carry material commercial value.
Recent Industry Developments
GE HealthCare - Intelligent Ultrasound Clinical AI Acquisition
In July 2024, GE HealthCare announced an agreement to acquire Intelligent Ultrasound Group PLC's clinical AI software business for approximately USD 51 million; the transaction was completed in the fourth quarter of 2024 [4]GE HealthCare. "GE HealthCare Announces Agreement to Acquire Clinical Artificial Intelligence Business from Intelligent Ultrasound." investor.gehealthcare.com. The acquisition added ScanNav Assist, a real-time image-recognition and guidance platform for obstetric and general-imaging workflows, strengthening GE HealthCare's automation capabilities in women's health imaging.
RadNet - See-Mode Technologies Acquisition
On June 4, 2025, RadNet completed its acquisition of See-Mode Technologies, whose ultrasound AI applications include thyroid imaging functionality cleared for clinical use in multiple markets [5]RadNet, Inc. "RadNet, Inc. Acquires See-Mode Technologies for Innovation in AI-Powered Ultrasound Diagnostics." nasdaq.com. RadNet reported that early deployment at its outpatient centers delivered up to 30% scan-time reduction through automated detection and standardized reporting, illustrating the operational value proposition of workflow-focused ultrasound AI.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →